Clinical Trial Update: Lesogaberan in Chinese Patients With Refractory Reflux Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on lesogaberan in Chinese patients with refractory reflux symptoms; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lesogaberan (lesogaberan)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: UNKNOWN